COPD
Research Roundup
Debbie Rigby rounds up the latest in research news Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease Among patients with COPD without exacerbations …
COPD and CVD comorbidity
Optimal management of COPD should include identification and management of comorbidities. As COPD has a high rate of comorbidity with cardiovascular disease, patients with COPD may benefit from cardioprotective medications …
Research Roundup
Debbie Rigby rounds up the latest in research news Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes In this population based …
Research Roundup
Debbie Rigby takes a look at the latest in research news Beta-blocker therapy in patients with COPD Beta-blockers are associated with reduced mortality in patients with cardiovascular disease but are …
Supporting patients with chronic respiratory disease
Resources supporting pharmacists to provide services to people with chronic respiratory diseases has been published by FIP The resources—covering asthma and chronic obstructive pulmonary disease—have just been released by the …
Research Roundup
Debbie Rigby rounds up the latest in research news COPD‐X Australian guidelines for the diagnosis and management of COPD This summary of the updated COPD-X guidelines highlights the importance of …
Medication adherence in COPD
Optimal management of COPD requires a combination of pharmacological and non-pharmacological strategies, however adherence to treatment can be low. Pharmacists can play a pivotal role in optimising adherence, persistence and …
Research Roundup
Debbie Rigby takes a look at the latest news in research Hormonal contraception and mood disorders Hormonal contraception is known to precipitate or perpetuate depression in some patients. The link …
Research Roundup
Debbie Rigby rounds up the latest in research news Dual bronchodilation for the treatment of COPD Dual bronchodilation with long-acting muscarinic receptor antagonists (LAMAs) and long-acting β-agonists (LABAs) fixed dose …
Guideline discrepancies in COPD, CF
Antibiotics used in the treatment of lower respiratory tract infections associated with COPD and CF: Discrepancies in guidelines Letter to the editor, by Nazrul Islam*,1,2 and Debbie Rigby3,4 Australian Medicines …
Minimising the risk of exacerbations in moderate-to-severe COPD: the pharmacist’s role
Pharmacists can have an important role in supporting their patients manage their COPD medications, inhaler selection and technique, as well as non-pharmacological strategies to help improve quality of life. By …
Research roundup
Debbie Rigby rounds up the latest in research news Risks and burdens of incident diabetes in long COVID A large US cohort study has found a 40% increased risk of …